Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 100 filers reported holding Y-MABS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $98,945 | -19.7% | 18,155 | 0.0% | 0.00% | – |
Q2 2023 | $123,273 | +4.2% | 18,155 | -23.1% | 0.00% | – |
Q1 2023 | $118,351 | +39.1% | 23,623 | +35.5% | 0.00% | – |
Q4 2022 | $85,068 | -65.7% | 17,432 | +1.4% | 0.00% | – |
Q3 2022 | $248,000 | -76.7% | 17,186 | -75.6% | 0.00% | -100.0% |
Q2 2022 | $1,064,000 | -70.6% | 70,336 | -76.9% | 0.00% | -50.0% |
Q1 2022 | $3,624,000 | +815.2% | 305,042 | +1150.1% | 0.00% | – |
Q4 2021 | $396,000 | -39.4% | 24,402 | +6.8% | 0.00% | – |
Q3 2021 | $653,000 | -31.0% | 22,857 | -18.4% | 0.00% | – |
Q2 2021 | $946,000 | +17.4% | 27,999 | +5.0% | 0.00% | – |
Q1 2021 | $806,000 | -43.7% | 26,670 | -7.8% | 0.00% | -100.0% |
Q4 2020 | $1,432,000 | +67.9% | 28,921 | +30.2% | 0.00% | 0.0% |
Q3 2020 | $853,000 | -27.6% | 22,214 | -18.6% | 0.00% | 0.0% |
Q2 2020 | $1,178,000 | -17.3% | 27,275 | -50.0% | 0.00% | 0.0% |
Q1 2020 | $1,425,000 | -71.7% | 54,589 | -66.1% | 0.00% | -66.7% |
Q4 2019 | $5,037,000 | +3048.1% | 161,249 | +2498.7% | 0.00% | – |
Q3 2019 | $160,000 | -56.5% | 6,205 | -61.5% | 0.00% | – |
Q2 2019 | $368,000 | +61.4% | 16,122 | +83.7% | 0.00% | – |
Q1 2019 | $228,000 | +19.4% | 8,774 | -7.2% | 0.00% | – |
Q4 2018 | $191,000 | – | 9,452 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 191,176 | $2,271,000 | 2.63% |
Sofinnova Investments, Inc. | 2,194,278 | $26,068,000 | 1.98% |
MPM BioImpact LLC | 443,702 | $5,271,000 | 1.42% |
Soleus Capital Management, L.P. | 238,982 | $2,839,000 | 0.37% |
Lombard Odier Asset Management (Switzerland) SA | 221,774 | $2,635,000 | 0.21% |
Artal Group S.A. | 400,000 | $4,752,000 | 0.20% |
Polar Capital Holdings Plc | 2,877,671 | $34,187,000 | 0.15% |
ASHFORD CAPITAL MANAGEMENT INC | 106,770 | $1,268,000 | 0.14% |
Cormorant Asset Management, LP | 150,000 | $1,782,000 | 0.14% |
Virtus ETF Advisers LLC | 23,646 | $281,000 | 0.13% |